TETRANEURON
Tetraneuron is a gene therapy biotech company. They develop disruptive multifactorial gene therapy to treat Alzheimer’s disease and a biomarker for early detection of this disease. They respond to customer inquiries by contact form and email.
TETRANEURON
Industry:
Biotechnology Medical Neuroscience Pharmaceutical
Founded:
2012-01-01
Address:
Valencia, Comunidad Valenciana, Spain
Country:
Spain
Website Url:
http://www.tetraneuron.com
Total Employee:
11+
Status:
Active
Contact:
+34 96 315 20 62
Email Addresses:
[email protected]
Total Funding:
8.5 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Font API WordPress LetsEncrypt SSL By Default Font Awesome
Similar Organizations
Advanced Neural Dynamics
Advanced Neural Dynamics is a drug discovery company that provides neuroprotection against agents causing neurological impairment.
B-SMART
B-SMART is an RNA-based therapy perspective for neurodegenerative diseases.
CNX Therapeutics
CNX Therapeutics is a pharmaceutical company that aims to commercialize and supply medications specific to CNS disorders.
Serometrix
Serometrix is a drug discovery company developing pharmaceutical drugs with a lower development cost.
Theraptosis
Theraptosis is a biopharmaceutical company that designs and develops various drugs for cancer and neurodegenerative diseases.
TheraSci
TheraSci is a drug discovery company that discovers and develops pharmaceutical compounds.
Investors List
Valencia Institute of Finance
Valencia Institute of Finance investment in Debt Financing - Tetraneuron
Région Sud Investissement
Région Sud Investissement investment in Debt Financing - Tetraneuron
Official Site Inspections
http://www.tetraneuron.com Semrush global rank: 12.95 M Semrush visits lastest month: 78
- Host name: vl27740.dinaserver.com
- IP address: 82.98.175.154
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Tetraneuron"
About us – Tetraneuron
At Tetraneuron, our team consists of scientists and biotechnology experts who have dedicated their careers to researching and developing gene therapies for neurodegenerative diseases. …See details»
Tetraneuron – A new path for neurodegenerative diseases
Tetraneuron is a biotech company focused on novel gene therapies for neurodegenerative diseases. Based in Madrid and Valencia, Tetraneuron emerges as a spin-off from the Cajal …See details»
Tetraneuron Company Profile 2024: Valuation, Funding …
Tetraneuron General Information Description. Developer of medical therapies intended to focus on the development of disruptive gene therapy for Alzheimer's disease The company's therapy uses the consequent neural tetraploidization …See details»
Tetraneuron - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 27, 2022: Funding Round …See details»
TETRANEURON Information - RocketReach
TETRANEURON is a drug discovery company, focused on the development of a disruptive Gene Therapy for Alzheimer’s disease (AD) and an Early Biomarker for this neurodegenerative …See details»
TETRANEURON - Org Chart, Teams, Culture & Jobs
View TETRANEURON's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Tetraneuron - Company Profile - Tracxn
Oct 28, 2024 Tetraneuron - Developer of therapies to treat Alzheimer's disease. Raised a total funding of $5M over 1 round from 1 investor. Founded by Cristina Payan Rodriguez and Lucia …See details»
TETRANEURON SL. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TETRANEURON SL. of VALENCIA, Valencia. Get the latest business insights from Dun & …See details»
Tetraneuron - Crunchbase
Organization. Tetraneuron . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. …See details»
Tetraneuron - Products, Competitors, Financials, Employees ...
Tetraneuron is a biotech company focused on developing innovative gene therapies for neurodegenerative diseases. Use the CB Insights Platform to explore Tetraneuron's full …See details»
Tetraneuron - Overview, News & Similar companies - ZoomInfo
Who is Tetraneuron. First Spanish biotech company accelerated by the Johnson & Johnson European Innovation Center, Tetraneuron (www.tetraneuron.com) has been developin g for …See details»
MARI CARMEN ÁLVAREZ - Longevity World Forum
CEO of Tetraneuron, where she leads the development of innovative gene therapies for neurodegenerative diseases such as Alzheimer’s disease. Mari Carmen Álvarez holds a PhD …See details»
Tetraneuron - Startup Valencia
Tetraneuron is a drug discovery company, focused on the development of a disruptive Gene Therapy for Alzheimer’s disease (AD) and an Early Biomarker for this neurodegenerative …See details»
Tetraneuron closes a financing round of more than 2.5 million euros
Tetraneuron, the biotechnology company led by Dr. José María Frade, a researcher at the Cajal Institute, closes a round of financing of more than 2.5 million euros. â € The Spanish biotech …See details»
TETRANEURON SL - F6S
TETRANEURON SL - Alzheimer’s disease (AD) is a progressive brain disorder that causes memory loss over time. In 2020, an estimated 5.8 million Americans were living with AD. By …See details»
Tetraneuron - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Dec 10, 2024 Organization. Tetraneuron . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 6. …See details»
Tetraneuron Company Information - Funding, Investors, and More …
The company Tetraneuron has raised a total of $5.32m in funding over 1 rounds. Key Insights: Seed: $5.32m; 2024. Tetraneuron Seed (2022, $5M) $5.32m. Discover Iwoca. Company size. …See details»
Tetraneuron´s vision. A couple of months ago we dedicated a
Sep 29, 2022 Tetraneuron Director. Nowadays, close to 800.000 people are affected by Alzheimer just in Spain. Spanish physicians usually identify about 40.000 new cases per year. …See details»
Research – Tetraneuron
At Tetraneuron, we are dedicated to bridging this innovative science from the lab to clinical practice, aiming to create a more hopeful future for patients impacted by neurodegenerative …See details»